First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial
| Autor: | Rydelius, Johanna *, Hognert, Helena, Kopp-Kallner, Helena, Brandell, Karin, Romell, Joanna, Zetterström, Karin, Teleman, Pia, Gemzell-Danielsson, Kristina |
|---|---|
| Zdroj: | In The Lancet 31 August-6 September 2024 404(10455):864-873 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|